Antibody-mediated rejection after intestinal transplantation

Current Opinion in Organ Transplantation

Volumn 17, Issue 3, 2012, Pages 250-257

  Dick, André A S ^a   Horslen, Simon ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

acute rejection; antibody mediated rejection; intestinal transplantation

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C2B; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C4D; COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; COMPLEMENT MEMBRANE ATTACK COMPLEX; CORTICOSTEROID; ECULIZUMAB; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ANTIBODY MEDIATED REJECTION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG MEGADOSE; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE BIOPSY; INTESTINE GRAFT; INTESTINE TRANSPLANTATION; PLASMAPHERESIS; PROGNOSIS; REVIEW; SPLENECTOMY; STAINING;

GRAFT REJECTION; HUMANS; IMMUNITY, HUMORAL; INTESTINE, SMALL; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 84861190912     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283533847     Document Type: Review

References (40)

1. Mazariegos GV, Steffick DE, Horslen S, et al. Intestine transplantation in the United States, 1999-2008. Am J Transplant 2010; 10:1020-1034.
2. Fisbein TM. The current state of intestinal transplantation. Transplantation 2004; 78:175-178.
3. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3:665-673. (Pubitemid 36745238)
4. Grant D, Abu-Elmagd K, Reyes J, et al., On behalf of the Intestine Transplant Registry. 2003 Report of the intestine transplant registry: a new era has dawned. Ann Surg 2005; 241:607-613. (Pubitemid 40397308)
5. Sauvat F, Dupic L, Caldari D, et al. Factors influencing outcome after intestinal transplantation in children. Transplant Proc 2006; 38:1689-1691. (Pubitemid 44190037)
6. Kfoury AG,HammondME.Controversiesindefiningcardiacantibody-mediated rejection: need for updated criteria. J Heart Lung Transplant 2010; 29:389-394.
7. Nair N, Ball T, Uber PA, Mehra MR. Current and future challenges in therapy for antibody-mediated rejection. J Heart Lung Transplant 2011; 30:612-617.
8. Terasaki P, Kazuo M. Antibody mediated rejection: update 2006. Clin J Am Soc Nephrol 2006; 1:400-403.
9. Reyes JD, Mazariegos GV, Bond GMD, et al. Pediatric intestinal transplantation: historical notes, principles and controversies. Pediatr Transplant 2002; 6:193-207.
10. Montgomery RA, Cozzi E, West LJ, et al. Humoral immunity and antibody- mediated rejection in solid organ transplantation. Semin Immunol 2011; 23:224-234.
11. Murata K, Baldwin WM. Mechanism of complement activation, C4d deposition and their contribution to the pathogenesis of antibody-mediated rejection. Transplant Rev 2009; 23:139-150.
12. Feucht HE, Felber E, Gokel MJ, et al. Vascular deposition of complement-split products in kidney allografts with cell mediated rejection. Clin Exp Immunol 1991; 86:464-470.
13. Feucht HE, Schneeberger H, Hillebrand G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43:1333-1338. (Pubitemid 23161421)
14. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10:464-471.
15. Rotman S, Collins AB, Colvin RB. C4d deposition in allografts: current concepts and interpretation. Transplant Rev 2005; 19:65-77. (Pubitemid 41194913)
16. Sis B, Jhangri GS, Riopel J, et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012. doi: 10.1111/j.1600-6143.2011.03931.x. [Epub ahead of print].
17. Berry GJ, Angelini A, Burke MM, et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: Evolution and current status (2005-2011). J Heart Lung Transplant 2011; 30:601-611.
18. Kozlowski T, Andreoni K, Schmitz J, et al. Sinusoidal C4d deposits in liver allografts indicate an antibody mediated response: diagnostic consideration in the evaluation of liver allografts. Liver Transpl 2012. doi: 10.1002/lt.23403. [Epub ahead of print].
19. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24:1710-1720. (Pubitemid 41641841)
20. Suh M, Sogawa H, Nair V, et al. Antibody mediated accelerated rejection of isolated intestinal transplant graft. Paper presented at the XII International Small Bowel Transplant Symposium, Washington, DC, USA; 2011.
21. Ruiz P, Carreno M, Weppler D, et al. Immediate antibody-mediated (hyper-acute) rejection in small bowel transplantation and relationship to cross-match status and donor-specific C4d-binding antibodies: case report. Transplant Proc 2010; 42:95-99.
22. Tsai HL, Island ER, Chang JW, et al. Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation. Transplantation 2011; 92:709-715.
23. FarmerD,Venick RS,WozniakL,etal.Theliver,spleenandpreformedantibodies are important predictors of survival after intestinal transplantation (ITx): analysis of a single-center, 20 year experience. Paper presented at the XII International Small Bowel Transplant Symposium, Washington, DC, USA; 2011.
24. Wozniak L, Venick R, Esmailian E, et al. The impact of positive PRSs, DSAs and crossmatches on rejection, graft loss and patient death after intestinal transplantation. Paper presented at the XII International Small Bowel Transplant Symposium, Washington, DC, USA; 2011.
25. Romano A, Tryphonopoulos P, Hsinlin T, et al. The significance of a rising donor specific antibody titer in the diagnosis and prognosis of intestinal rejection. Paper presented at the XII International Small Bowel Transplant Symposium, Washington, DC, USA; 2011.
26. Gonzalez-Pinto IM, Tzakis AG, Tsai HL, et al. Association between panel reactive antibodies and acute small bowel rejection: analysis of a series of 324 intestinal transplants. Transplant Proc 2010; 42:4269-4271.
27. Gozzini S, Briggs D, Evans A, et al. Is there a role of HLA antibodies in early onset of acute rejection after pediatric intestinal and multivisceral transplantation? Paper presented at the XII International Small Bowel Transplant Symposium, Washington, DC, USA; 2011.
28. Patey-Mariaud de Serre N, Canioni D, Lacaille F, et al. Evaluation of C4d deposition and circulating antibody in small bowel transplantation. Am J Transplant 2008; 8:1290-1296. (Pubitemid 351763676)
29. Gerlach U, Schoenemann C, Lachmann N, et al. Clinical relevance of HLA-antibodies after intestinal transplantation. Paper presented at the XII International Small Bowel Transplant Symposium, Washington, DC, USA; 2011.
30. Troxell ML, Higgins JP, Kambham N. Evaluation of C4d staining in liver and small intestine allografts. Arch Pathol Lab Med 2006; 130:1489-1496. (Pubitemid 44520715)
31. Takahashi H, Kato T, Mizutani K, et al. Simultaneous antibody-mediated rejection of multiple allografts in modified multivisceral transplantation. Clin Transpl 2006; 20:529-534.
32. Jordan SC,Vo AA, Tyan D, Nast CC,et al. Current approaches to treatment of antibody mediated rejection. Pediatr Transplant 2005; 9:408-415. (Pubitemid 40780375)
33. Jordan SC, Tyan D, Czer L, et al. Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ recipients. Pediatr Transplant 1998; 2:92-105. (Pubitemid 128655513)
34. Clatworthy MR. Targeting B cells and antibody in transplantation. Am J Transplant 2011; 11:1359-1367.
35. Borker A, Choudhary N. Rituximab. Indian Pediatr 2011; 48:627-632.
36. Waddle ES, Alloway RR, Girnita A. Proteasome inhibitor treatment of antibody-mediated rejection. Curr Opin Organ Transplant 2011; 16:434-438.
37. Stegall MD, Gloor JM. Deciphering antibody-mediated rejection: new insights into mechanisms and treatments. Curr Opin Organ Transplant 2010; 15:8-10.
38. Lacaille F, Petit LM, Canioni D, et al. Humoral rejection after intestinal transplantation. Paper presented at the XII International Small Bowel Transplant Symposium, Washington, DC, USA; 2011.
39. Island ER, Gonzalez-Pinto IM, Tsai HL, et al. Successful treatment with bortezomib of a refractory humoral rejection of the intestine after multivisceral transplantation. Clin Transpl 2009; 23:465-469.
40. GerlachU,SchoenemannC,Lachmann N, etal. Salvage therapy for refractory rejection and persistence of donor-specific antibodies after intestinal transplantation using the proteasome inhibitor bortezomib. Transpl Int 2011; 24:e43-e45.